Localization and up‐regulation of Mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis

Using digoxigenin–UTP‐labelled human HAM‐1 (92 bp) or SMUC41 (850 bp) cRNA probes, the expression and localization of MUC2 gene transcripts were determined by in situ hybridization in human nasal tissues obtained as biopsies from 12 patients with cystic fibrosis (CF): all had been part of a gene therapy trial in which CFTR cDNA–liposome complexes had been delivered by topical application to eight and liposome alone to four as a placebo control. For comparison, there were nasal tissues taken at surgical resection from four non‐CF subjects and a further four biopsies taken from normal healthy volunteer controls. Both SMUC41 and HAM‐1 probes provided a strong signal. MUC2 mRNA transcripts were present in serous and mucous acini of submucosal glands, ciliated and basal cells of the surface epithelium, and occasional mononuclear inflammatory cells. The percentages (mean±SEM) of serous and mucous acini showing positivity for MUC2 gene expression in the four samples surgically resected from non‐CF subjects were 25·4±5·6 and 26·7±3·3 per cent, respectively. Compared with the non‐CF subjects, the mean percentage of acini showing MUC2 gene expression in the four placebo‐treated CF subjects was significantly higher for serous (80·5±12·7 per cent; P<0·05, t‐test), but not for mucous acini (53·1±16·8 per cent; P=0·38). In CF and non‐CF groups, where present, MUC2 positivity was strongly expressed and constituted approximately 84 per cent of the cell area in serous acini, whereas it was less obvious and was confined to the perinuclear area of cells in mucous acini. A significantly greater proportion of the surface epithelium was positive for MUC2 mRNA transcripts in the CF subjects (89·0, ±1·4 per cent) than in the surgically resected tissues of the four non‐CF subjects (19·4, ±4·0 per cent) (P=0·02). In the eight CFTR‐cDNA‐treated subjects, there was an overall trend to reduction, but no statistically significant alteration of MUC2 gene expression. It is concluded that the MUC2 gene is expressed at three‐ tofour‐fold higher levels in CF nasal mucosa than in non‐CF nasal tissue and that it is expressed in a variety of cells additional to submucosal mucus‐secreting glands. © 1997 John Wiley & Sons, Ltd.

[1]  R. de Haller,et al.  Insufficient oxygen concentration obtained at domiciliary controls of eighteen concentrators. , 1989, The European respiratory journal.

[2]  E. Schenborn,et al.  A novel transcription property of SP6 and T7 RNA polymerases: dependence on template structure. , 1985, Nucleic acids research.

[3]  T. Irimura,et al.  Regulation of sialomucin production in colon carcinoma cells. , 1993, The Journal of biological chemistry.

[4]  C. Herrington,et al.  Model system for optimising mRNA non-isotopic in situ hybridisation: riboprobe detection of lysozyme mRNA in archival gut biopsy specimens. , 1991, Journal of clinical pathology.

[5]  J M Zahm,et al.  Role of the physicochemical properties of mucus in the protection of the respiratory epithelium , 2012 .

[6]  Y. Kim,et al.  Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. , 1989, The Journal of biological chemistry.

[7]  H. Boushey,et al.  Use of mucin antibodies and cDNA probes to quantify hypersecretion in vivo in human airways. , 1994, American journal of respiratory cell and molecular biology.

[8]  W. Finkbeiner,et al.  Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas. , 1993, American journal of respiratory cell and molecular biology.

[9]  G. Lamblin,et al.  Human respiratory mucins. , 1992, The European respiratory journal.

[10]  N. Peat,et al.  Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. , 1990, The Journal of biological chemistry.

[11]  W. Kuo,et al.  Human gastric mucin. Identification of a unique species by expression cloning. , 1993, The Journal of biological chemistry.

[12]  W. Kendrick,et al.  Histochemistry of mucosubstances in the canine and human respiratory tract. , 1971, Laboratory investigation; a journal of technical methods and pathology.

[13]  P. Jeffery,et al.  Proliferation and differentiation in mammalian airway epithelium. , 1988, The European respiratory journal.

[14]  C. Basbaum,et al.  Mucin in disease. Modification of mucin gene expression in airway disease. , 1991, The American review of respiratory disease.

[15]  S. Gendler,et al.  The epithelial mucin, MUC1, of milk, mammary gland and other tissues. , 1995, Biochimica et biophysica acta.

[16]  M. Copin,et al.  Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  M. Hollingsworth,et al.  Developmental expression of mucin genes MUC1 and MUC2. , 1994, Journal of cell science.

[18]  S. Batra,et al.  Cloning and sequencing of a human pancreatic tumor mucin cDNA. , 1990, The Journal of biological chemistry.

[19]  Y. Kim,et al.  Human bronchus and intestine express the same mucin gene. , 1991, The Journal of clinical investigation.

[20]  R. Wu,et al.  Expression of MUC2 gene is down-regulated by vitamin A at the transcriptional level in vitro in tracheobronchial epithelial cells. , 1994, American journal of respiratory cell and molecular biology.

[21]  A. Biesbrock,et al.  Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). , 1993, The Journal of biological chemistry.

[22]  J. Voynow,et al.  Quantitation of mucin mRNA in respiratory and intestinal epithelial cells. , 1994, American journal of respiratory cell and molecular biology.

[23]  V. G. Dupérat,et al.  Structural features of the core proteins of human airway mucins ascertained by cDNA cloning. , 1991, The American review of respiratory disease.

[24]  D. Swallow,et al.  Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. , 1990, Biochemical and biophysical research communications.

[25]  M. Gross,et al.  Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. , 1991, Biochemical and biophysical research communications.

[26]  B. Debuire,et al.  Evidence for different human tracheobronchial mucin peptides deduced from nucleotide cDNA sequences. , 1991, American journal of respiratory cell and molecular biology.

[27]  M. Cardone,et al.  Distribution of lysozyme and mucin (MUC2 and MUC3) mRNA in human bronchus. , 1994, Experimental lung research.

[28]  F. Collins,et al.  Cystic fibrosis: molecular biology and therapeutic implications. , 1992, Science.

[29]  M. Rose.  Characterization of human tracheobronchial mucin glycoproteins. , 1989, Methods in enzymology.

[30]  S. Durham,et al.  Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis , 1995, Nature Medicine.